Disease | von hippel-lindau syndrome |
Phenotype | C0206734|hemangioblastomas |
Sentences | 12 |
PubMedID- 20192620 | Functional outcome after resection of spinal cord hemangioblastomas associated with von hippel-lindau disease. |
PubMedID- 22374327 | Pazopanib therapy for cerebellar hemangioblastomas in von hippel-lindau disease: case report. |
PubMedID- 24379949 | Ammerman et al.2) reported that "long-term natural history of hemangioblastomas in patients with von hippel-lindau disease", excluding those in a supratentorial location, had a stuttering or stepwise growth pattern. |
PubMedID- 24340227 | Background: hemangioblastomas are associated with von hippel-lindau disease (vhld) in 10-40% of cases. |
PubMedID- 21959491 | Review of "natural history of supratentorial hemangioblastomas in von hippel-lindau disease". |
PubMedID- 22347675 | Early microsurgical treatment for spinal hemangioblastomas improves outcome in patients with von hippel-lindau disease. |
PubMedID- 25390717 | Conclusion: combined intravitreal bevacizumab with laser photocoagulation is a viable option in retinal capillary hemangioblastomas associated with von hippel-lindau syndrome. |
PubMedID- 20150370 | Prospective evaluation of radiosurgery for hemangioblastomas in von hippel-lindau disease. |
PubMedID- 25816089 | Editorial: management of hemangioblastomas in patients with von hippel-lindau disease: stereotactic radiosurgery compared to surgical excision. |
PubMedID- 20647972 | Natural history of supratentorial hemangioblastomas in von hippel-lindau disease. |
PubMedID- 26235016 | Seven (43.75%) of the 16 patients had associated von hippel-lindau syndrome, with hemangioblastomas also presenting in other locations. |
PubMedID- 24680832 | [epidemiology, treatment and follow-up of central nervous system hemangioblastomas in von hippel-lindau disease]. |
Page: 1